Related references
Note: Only part of the references are listed.Differences in the Clinical Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Critical Review of the Evidence
Csaba Andras Dezsi
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2014)
Association of Postdischarge Rehabilitation with Mortality in Intensive Care Unit Survivors of Sepsis
Pei-wen Chao et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Long-Term Clinical Outcome of Major Adverse Cardiac Events in Survivors of Infective Endocarditis A Nationwide Population-Based Study
Chia-Jen Shih et al.
CIRCULATION (2014)
Use of Antidiabetic Drugs in the U. S., 2003-2012
Christian Hampp et al.
DIABETES CARE (2014)
The dipeptidyl peptidase-4 inhibitor vildagliptin does not affect ex vivo cytokine response and lymphocyte function in patients with type 2 diabetes mellitus
P. C. M. van Poppel et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2014)
Dipeptidyl peptidase-4 inhibitor sitagliptin significantly reduced hepatitis C virus replication in a diabetic patient with chronic hepatitis C virus infection
Hidekatsu Yanai
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2014)
Metformin in Patients With Type 2 Diabetes and Kidney Disease A Systematic Review
Silvio E. Inzucchi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Metformin inhibits hepatitis B virus protein production and replication in human hepatoma cells
Y. -H. Xun et al.
JOURNAL OF VIRAL HEPATITIS (2014)
Diet Modification and Metformin Have a Beneficial Effect in a Fly Model of Obesity and Mucormycosis
Fazal Shirazi et al.
PLOS ONE (2014)
Metformin as adjunct antituberculosis therapy
Amit Singhal et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Diabetes prescribing in England consumes nearly 10% of primary care budget
Gareth Iacobucci
BMJ-BRITISH MEDICAL JOURNAL (2014)
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
V. Stalin Raj et al.
NATURE (2013)
Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose
James P. Garnett et al.
THORAX (2013)
Glibenclamide reduces pro-inflammatory cytokine production by neutrophils of diabetes patients in response to bacterial infection
Chidchamai Kewcharoenwong et al.
SCIENTIFIC REPORTS (2013)
Impact of metformin use on the prognostic value of lactate in sepsis
Jeffrey P. Green et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2012)
Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register
Nils Ekstrom et al.
BMJ OPEN (2012)
Long-Term Dipeptidyl-Peptidase 4 Inhibition Reduces Atherosclerosis and Inflammation via Effects on Monocyte Recruitment and Chemotaxis
Zubair Shah et al.
CIRCULATION (2011)
Glyburide Is Anti-inflammatory and Associated with Reduced Mortality in Melioidosis
Gavin C. K. W. Koh et al.
CLINICAL INFECTIOUS DISEASES (2011)
Use of Dipeptidyl Peptidase-4 Inhibitors and the Reporting of Infections: A Disproportionality Analysis in the World Health Organization VigiBase
Marjolein J. Willemen et al.
DIABETES CARE (2011)
National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants
Goodarz Danaei et al.
LANCET (2011)
ATP-sensitive potassium channel (KATP)-dependent regulation of cardiotropic viral infections
Ioannis Eleftherianos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Long-term use of thiazolidinediones and the associated risk of pneumonia or lower respiratory tract infection: systematic review and meta-analysis
Sonal Singh et al.
THORAX (2011)
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
Shelley R. Salpeter et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2010)
Glyburide inhibits the Cryopyrin/Nalp3 inflammasome
Mohamed Lamkanfi et al.
JOURNAL OF CELL BIOLOGY (2009)
Metformin, Sulfonylureas, or Other Antidiabetes Drugs and the Risk of Lactic Acidosis or Hypoglycemia A nested case-control analysis
Michael Bodmer et al.
DIABETES CARE (2008)
The IRIS v study:: Pioglitazone improves systemic chronic inflammation in patients with type 2 diabetes under daily routine conditions
Efstrathios Karagiannis et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2008)
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial
JA Dormandy et al.
LANCET (2005)
Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial
JFE Mann et al.
ANNALS OF INTERNAL MEDICINE (2001)
Share Paper
